Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging

Clinical Nuclear Medicine

Volumn 23, Issue 2, 1998, Pages 93-98

  Hollinger, Edward F ^a   Alibazoglu, Haluk ^a   Ali, Amjad ^a   Green, Alexander ^a   Lamonica, Gregory ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bone Marrow Uptake; Colony Stimulating Factors; FDG PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; BONE MARROW; BONE MARROW METASTASIS; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; HEMATOPOIESIS; HUMAN; OSTEOSARCOMA; POSITRON EMISSION TOMOGRAPHY;

ADOLESCENT; ADULT; BONE MARROW; BONE MARROW NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OSTEOSARCOMA; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031913913     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199802000-00007     Document Type: Article

References (21)

1. Warburg O: On the origin of cancer cells. Science 123: 309, 1956.
2. Phelps ME, Huang S-C, Hoffman EJ, et al: Tomographic measurement of local cerebral glucose metabolic rates in humans with (F-18)-deoxy-D-glucose: Validation of method. Ann Neurol 6: 371, 1979.
3. Rervich M, Kuhl DE, Wolf A, et al: The (18F)-fluorodeoxyglucose method for measurement of local cerebral glucose utilization in man. Circ Res 44: 127, 1979.
4. Hoh CK, Hawkins RA, Glaspy JA, et al: Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose. J Comput Assist Tomogr 17: 582, 1993.
5. Strauss LG, Conti PS: The applications of PET in clinical oncology. J Nucl Med 32: 623, 1991.
6. Glaspy JA, Hawkins R, Hoh CK, et al: Use of positron emission tomography in oncology. Oncology 7: 41, 1993.
7. Ichiya Y, Kuwabara Y, Sasaki M, et al: FDG-PET in infectious lesions: The detection and assessment of lesion activity. Ann Nucl Med 10: 185, 1996.
8. Yamada S, Kubota K, Kubota R, et al: High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 36: 1301, 1995.
9. Hamilton JA, Vario G, Lingelbach SR. CSF-1 stimulates glucose uptake in murine bone marrow-derived macrophages. Biochem Biophys Res Commun 138: 455, 1986.
10. Knopp MV, Bischoff H, Rimac A, et al: Bone marrow uptake of fluorine-18-fluorodeoxyglucose following treatment with hematopoictic growth factors: Initial evaluation. Nucl Med Biol 23: 845, 1996.
11. Yao W-J, Hoh CK, Hawkins RA, et al: Quantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines. J Nucl Med 36: 794, 1995.
12. Bertini M, Freilone R, Vitolo U, et al: P-VEBEC: A new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma. Ann Oncol 5: 895, 1994.
13. Hansen F: Hemopoietic growth and inhibitory factors in treatment of malignancies. Acta Oncol 34: 453, 1995.
14. Trillet-Lenior V, Soler P, Arpin D, et al: The limits of chemotherapy dose intensification using granulocyte colony stimulating factor alone in extensive small cell lung cancer. Lung Cancer 14: 331, 1996.
15. Iversen PO, Nicolaysen G, Benestad HB: Endogenous nitric oxide causes vasodilation in rat bone marrow, bone, and spleen during accelerated hematopoiesis. Exp Hematol 22: 1297, 1994.
16. Ryan EP, Weinberger E, White KS, et al: MR imaging of bone marrow in children with osteosarcoma: Effect of granulocyte colony-stimulating factor. Am J Roentgenol 165: 915, 1995.
17. Jensen KE, Hansen PB, Larsen VA, et al: Short-term myeloid growth factor mediated expansion of bone marrow haemopoiesis studied by localized magnetic resonance proton spectroscopy. Br J Haematol 88: 465, 1994.
18. Stokkel MPM, Olmos RAV, Hoefnagel CA, et al: Tumor and therapy associated abnormal changes on bone scintography: Old and new phenomena. Clin Nucl Med 18: 821, 1992.
19. Abdel-Dayem HM, Sanchez J, Al-Mohannadi S, et al: Diffuse thallium-201-chloride uptake in hypermetabolic bone marrow following treatment with granulocyte stimulating factor. J Nucl Med 33: 2014, 1992.
20. Berlangieri SU, Peters WP, Coleman RE: Distribution of Tc-99m-sulphur colloid during granulocyte colony-stimulating factor administration in autologous bone marrow transplantation. Nucl Med Commun 14: 896, 1993.
21. de Haan G, Dontje B, Engel C, et al: The kinetics of murine hematopoetic stem cells in vivo in response to prolonged increased blood cell production induced by granulocyte colony-stimulating factor. Blood 86: 2986, 1995.